Anti-Spike Monoclonal Antibody Monotherapies and Immune Escape Risk Minimization Strategies.

Journal Article Accepted manuscript Anti-Spike monoclonal antibody monotherapies and immune escape risk minimization strategies Get access Arturo Casadevall, Arturo Casadevall Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA corresponding author: acasade1@jhu.edu. https://orcid.org/0000-0002-9402-9167 Search for other works by this author on: Oxford Academic PubMed Google Scholar Daniele Focosi Daniele Focosi North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciae254, https://doi.org/10.1093/cid/ciae254 Published: 13 May 2024 Article history Received: 26 March 2024 Accepted: 06 May 2024 Published: 13 May 2024